Abstract:
The present invention is generally related to virus-like particles (VLPs) comprising rabies virus (RV) glycoproteins (G proteins) and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of rabies virus infection.
Abstract:
Described are a system and method for performing an automated quality assessment on a software program under test. A test automation system executes a test on a software program Data related to the test is automatically collected. The data includes first information determined by the test automation system in response to executing the test. The data further includes second information related to the test and received from a source other than the test automation system. The first information is analyzed. A quality assessment of the software program is generated from the analyzed first information and from the second information.
Abstract:
A DC-DC Buck circuit has a DC input terminal, a DC output terminal, a ground terminal, an inductor, a capacitor, a sampling resistor, a PWM control chip and a DrMOS chip. The output of the driver pin of the PWM control chip is unrelated to the voltage between the inductor and the sampling resistor. The DC-DC Buck circuit can produce a larger output voltage while also being compatible with a DrMOS chip.
Abstract:
The present invention provides isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also provides nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Abstract:
There is presently provided a stimulus-responsive polymer comprising a biodegradable polymer backbone and a stimulus-responsive pendant group attached to the biodegradable polymer backbone, wherein the biodegradable polymer backbone comprises a poly(amino ester) or a poly(amido amine), the poly(amido amine) optionally comprising a disulfide linkage in the backbone.
Abstract:
The present invention relates to the method for manufacturing textile, by treating textile with an isolated polypeptide having endoglucanase activity, especially in biostoning and bio-polishing process.
Abstract:
In described embodiments, a transceiver includes an eye monitor, clock and data recovery, and adaptation modules. Data sampling clock phase and error clock phase determined from a data eye are decoupled in the transceiver during a sampling phase correction process. Decoupling these clock phases during the sampling phase correction process allows relative optimization of system equalization parameters without degradation of various adaptation algorithms. Such adaptation algorithms might be employed for received signal gain and equalization such as, for example, Decision Feedback Equalizer (DFE) adaptation. Deriving the data sampling clock and error clock phases from the same clock generation source and with independent clock control enables an iterative sampling phase correction process that allows for accelerated clock and data recovery (CDR) without disturbing the data eye shape.
Abstract:
A receiver has an input and a decision feedback equalizer (DFE). The DFE couples to the receiver input and has at least one tap coefficient. An input signal, having a first amplitude level insufficient to cause significant non-linear distortion in the receiver, is applied to the receiver input. After the DFE adapts to the applied input signal having the first amplitude level by adjusting the at least one tap coefficient, the adaptation process is stopped. Then the at least one tap coefficient is scaled by a factor α and the amplitude of input signal is adjusted to a second amplitude level greater than the first amplitude level by the scale factor α. Although the second amplitude level might be sufficient to cause significant non-linear distortion in the receiver, the scaled tap coefficient has the correct values for proper DFE operation in the presence of the non-linear distortion.
Abstract:
The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Abstract:
The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.